Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Operating Leases: 2019-2020

Historic Operating Leases for Cogent Biosciences (COGT) over the last 2 years, with Dec 2020 value amounting to $3.2 million.

  • Cogent Biosciences' Operating Leases fell 61.04% to $1.4 million in Q3 2021 from the same period last year, while for Sep 2021 it was $1.4 million, marking a year-over-year decrease of 61.04%. This contributed to the annual value of $3.2 million for FY2020, which is 28.51% down from last year.
  • As of FY2020, Cogent Biosciences' Operating Leases stood at $3.2 million, which was down 28.51% from $4.4 million recorded in FY2019.
  • In the past 5 years, Cogent Biosciences' Operating Leases registered a high of $4.4 million during FY2019, and its lowest value of $3.2 million during FY2020.
  • For the 2-year period, Cogent Biosciences' Operating Leases averaged around $3.8 million, with its median value being $3.8 million (2019).
  • Data for Cogent Biosciences' Operating Leases shows a maximum YoY declined of 28.51% (in 2020) over the last 5 years.
  • Over the past 2 years, Cogent Biosciences' Operating Leases (Yearly) stood at $4.4 million in 2019, then decreased by 28.51% to $3.2 million in 2020.